Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals
It is expected to become the world's first heavyweight iteration of a major item to be launched on the market HONG KONG SAR - Media OutReach Newswire - 7 October 2024 - AIM Vaccine announced on the evening of October 6 that the company has received …